HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silke Niemann Selected Research

Silke Niemann Research Topics

Disease

15Infections
10/2021 - 03/2011
3Inflammation (Inflammations)
01/2020 - 01/2017
2Septic Shock (Toxic Shock Syndrome)
01/2021 - 01/2014
2Osteomyelitis
01/2018 - 11/2014
2Necrotizing Pneumonia
10/2013 - 10/2012
2Human Influenza (Influenza)
10/2013 - 10/2012
1Bacteremia
01/2020
1Wounds and Injuries (Trauma)
01/2020
1Cystic Fibrosis (Mucoviscidosis)
01/2020
1Bacterial Infections (Bacterial Infection)
01/2018
1Soft Tissue Infections
01/2017
1Staphylococcal Infections
01/2017
1Persistent Infection
04/2015

Drug/Important Bio-Agent (IBA)

3Virulence Factors (Pathogenicity Factors)IBA
01/2020 - 11/2014
2Hemolysin Proteins (Hemolysins)IBA
01/2021 - 01/2017
2Panton-Valentine leukocidinIBA
01/2017 - 10/2013
1Fibronectins (Fibronectin)IBA
10/2021
1Leukocidins (Leukocidin)IBA
01/2020
1Polyurethanes (Polyurethane)IBA
01/2020
1Superoxides (Superoxide)IBA
01/2020
1Antiviral Agents (Antivirals)IBA
01/2020
1VaccinesIBA
01/2020
12- (2- chloro- 4- iodophenylamino)- N- 3,4- difluorobenzoic acidIBA
01/2018
12- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA
01/2018
1AntibodiesIBA
01/2018
1Pharmaceutical PreparationsIBA
01/2018
1Mitogen-Activated Protein KinasesIBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
01/2017
1CytokinesIBA
01/2017
1lipoteichoic acidIBA
01/2017
1Sigma FactorIBA
04/2015
1ProteomeIBA
04/2015
1Interferon-betaIBA
03/2015
1InterferonsIBA
03/2015
1Chemotactic FactorsIBA
10/2012
1Anti-Bacterial Agents (Antibiotics)IBA
03/2011

Therapy/Procedure

3Therapeutics
04/2015 - 03/2011
2Catheters
01/2020 - 02/2017
1Transcatheter Aortic Valve Replacement
01/2014